Close-up TV News - Prolotheray lecture

Reversing Hypertension

Heavy Metals and all diseases

Close-Up TV News - Dr. Calapai's approach

News 12 Interview: Parkinson’s Disease, Glutathione and Chelation Therapy

News 12 Interview: Platelet-rich plasma therapy

Prolotherapy Interview News 12

News 12 Interview: Diabetes and Weight Loss
Efficacy of nonablative laser treatment for rhytids: A controlled study with objective evaluation via clinical, profilometric, and computer assessments *

Background A 980-nm diode laser was evaluated in rhytids treatment to ascertain its short- and long-term efficacy, as well as its potential value as an adjunct to aesthetic surgery.
Subjects and methods Twenty subjects, 10 in each of 2 geographically distant sites, were treated with a 980-nm diode laser (macropulse of 1.9 seconds, two 200-ms micropulses, 25 J/cm2 each). Group A subjects received 5 treatments, 15 days apart, with assessments at 1 and 6 months after the last treatment. Group B subjects received 2 treatment sessions, 30 days apart, with assessments at 1 and 6 months after the second treatment. The patient subjective satisfaction index (SI) was calculated, in addition to objective photographic, computer-based, profilometric, and histologic assessments.
Results Results were rated more highly by objective evaluation than by subjective patient evaluation. Improvement peaked around 1 month after the final treatment, and by the 6-month assessment, the skin condition had started to deteriorate. Among all evaluation methods, only the histology values showed some improvement at the 6-month compared with the 1-month assessment point. Group A patients responded better than Group B patients, and side effects were minimal.
Conclusions A course of 5 treatments with the 980-nm diode laser gave positive short-term results in skin enhancement following nonablative rhytids treatment, which might have significance for the plastic surgeon when considering epidermal improvement after any surgical procedure. Introducing a “top-up” treatment, perhaps at the 3- or 4-month posttreatment point, supplemented with other adjunctive epidermal care regimens, might well increase overall efficacy and reverse the downward trend seen in all of the data except for histology. This strategy might well help the epidermis to better reflect the excellent histologic changes and is worthy of further study.

* Legal Disclaimer: Chelation and Hyperbaric Therapy, Stem Cell Therapy, and other treatments and modalities mentioned or referred to in this web site are medical techniques that may or may not be considered “mainstream”. As with any medical treatment, results will vary among individuals, and there is no implication or guarantee that you will heal or achieve the same outcome as patients herein.

As with any procedure, there could be pain or other substantial risks involved. These concerns should be discussed with your health care provider prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

THE INFORMATION IN THIS WEBSITE IS OFFERED FOR GENERAL EDUCATIONAL PURPOSES ONLY AND DOES NOT IMPLY OR GIVE MEDICAL ADVICE. No Doctor/Patient relationship shall be deemed to have arisen simply by reading the information contained on these pages, and you should consult with your personal physician/care giver regarding your medical treatment before undergoing any sort of treatment or therapy.

Published on 09-08-2008
Authors: Mario A. Trelles MD, PhD1, , Jean-Luc Levy MD2 and Xavier Alvarez MD1
Source: American Society for Aesthetic Plastic Surgery, Inc. Published by Mosby, Inc